New on the Clinical Pipeline: FDA approves Genentech’s bispecific antibody for lymphoma
On 22 December 2022, the US Food and Drug Administration granted accelerated approval to mosunetuzumab-axgb, Genentech’s full-length bispecific monoclonal antibody that targets the B cell–specific surface antigen CD20 and the T cell surface protein CD3, for adults with relapsed or refractory follicular lymphoma. The drug received
from the European Medicines Agency in June 2022. Both agencies expect to receive follow-up information from Genentech to confirm the submitted efficacy data.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Nature Medicine - Liquid biopsies in colorectal cancerIn this issue, Oki et al. show an association between circulating tumor DNA after surgery and recurrence risk in patients with colorectal cancer. The test...
Read more »
Persistent mutation burden drives sustained anti-tumor immune responses - Nature MedicineGenomic analyses in large cohorts of patients with cancer identify a new measure of tumor mutational burden, based on genomic regions that are unlikely to undergo loss, that is associated with therapeutic response to immunotherapy ValsamoA NoushinNiknafs
Read more »
Putin says Russia is facing a shortage of medicine due to war with UkrainePresident Vladimir Putin said Russia is facing a shortage of certain medicines amid its war with Ukraine, even though the country is producing more of its own drugs domestically.
Read more »
Manchester Experimental Cancer Medicine Centre gets funding boostManchester Experimental Cancer Medicine Centre will get £3m to help it trial drugs and therapies.
Read more »
Origami is revolutionizing technology, from medicine to spaceOrigami is now pushing the limits of what scientists think is possible—at the tiniest of scales. Read more about how the art form has provided a new tool kit to ignite the imagination and create technologies once thought impossible in our February issue:
Read more »
Gregory A. Clark: Medicine by legislative fiat can be injurious and even deadlyGregory A. Clark: 'Utah politicians routinely argue for reducing government interference in family life. Overriding someone else’s self-identity is among the most egregious personal violations of all.'
Read more »